Interesting times, page-9

  1. 4,052 Posts.
    lightbulb Created with Sketch.  115
    "Can you find a complete response and name the reported study?"

    Anybody want to have a crack at that question? Because the NOX ASX release of the 21st of March is claiming a complete response.... "This case meets the definition of a complete abscopal response."
    It states that it was outside the formal companies study programs but case one is lacking a lot of information on dosage and timing. In fact it says nothing on dosages.

    "NOX66 self administered prior to, during and immediately after RT" http://www.noxopharm.com/irm/PDF/1522_1/TROGAnnualScientificMeetingNoxopharmPresentation21318

    Prior to? How prior...a week, a month.......years?

    How does that pass as valid information when there is no proof of supervision by a clinician. How does a patient get hold of NOX66 back in 2014 and self administer. Compare that to "case two" and the details of dosage and you can see the contrasting lack.....

    "Completed 5 x 21-day cycles NOX66 / doxorubicin (60mg/kg) ▪ NOX66 was 400mg for cycles 1-3, increased to 800mg cycles 4-5 ▪ NOX66 for Days 1-7, doxorubicin on day 2"
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
8.2¢
Change
0.002(2.50%)
Mkt cap ! $24.57M
Open High Low Volume
8.1¢ 8.2¢ 8.1¢ 28.31K

Buyers (Bids)

Vol. Price($)
126683 8.2¢
 

Sellers (Offers)

Price($) Vol.
8.8¢ 5819
Last trade - 16.15pm 10/08/2026 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.